Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$112,551,013
+$38,586,578 QoQ
Shares Held
981,521
+10.5% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#18
of 273 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $5,177,847,011 across 257 Biotechnology names. KYMR ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,019,315 | $1,499,784,339 | |
| 2 | ARGX |
Argenx SE
|
395,661 | $367,082,405 | |
| 3 | GMAB |
Genmab A/S
|
8,644,877 | $237,474,771 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
292,338 | $182,284,436 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,002,026 | $141,443,136 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,696,538 | $132,788,029 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
This page
|
981,521 | $112,551,013 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,453,504 | $108,256,977 |
All Filings in KYMR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $112,551,013 | 981,521 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $73,964,435 | 888,035 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $74,080,177 | 952,065 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,760,325 | 48,769 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,052,825 | 47,040 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,231,376 | 44,990 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,550,136 | 88,246 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $5,897,980 | 124,614 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,795,989 | 93,668 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,104,540 | 102,103 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $977,664 | 38,400 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $528,200 | 38,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $873,620 | 38,000 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,125,940 | 38,000 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $948,480 | 38,000 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $827,260 | 38,000 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $748,220 | 38,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,607,504 | 61,614 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,330,083 | 36,700 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,155,758 | 36,700 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $1,823,600 | 37,600 | Shares | Defined | 2021-07-30 | |
| 2021-03-31 | $419,688 | 10,800 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $421,600 | 6,800 | Shares | Defined | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||